Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: M&A

Expect Intensified M&A Activity with Bio-Pharmaceutical Companies Leading to an Active 2021 & Beyond

While life sciences-focused mergers and acquisition activity in 2020 was expected to dip, at least a bit due to the […]

Expect Intensified M&A Activity with Bio-Pharmaceutical Companies Leading to an Active 2021 & Beyond
4 days ago
Share

Bioclinica Acquires Brand New Silicon Valley AI Startup to Automate Medical Imaging & Accelerate Digital Diagnostic Development

Artificial intelligence (AI) will become an ever more important underlying force in the drug development process, from discovery through clinical […]

Bioclinica Acquires Brand New Silicon Valley AI Startup to Automate Medical Imaging & Accelerate Digital Diagnostic Development
2 months ago
Share

Trial Site Mavens: Edgemont Partners Matches Private Equity with Trial Site Organizations

As the clinical research space continues to adapt, advance and evolve, TrialSite chronicles a number of trends, including the ongoing […]

Trial Site Mavens Edgemont Partners Matches Private Equity with Trial Site Organizations
2 months ago
Share

Emmes Expands Presence in Europe with Neox Acquisition: Crosses 1K Employee Mark and Grows in CRO Stature

A Rockville Maryland-based global, full-service clinical research organization (CRO) recently acquired a European-based CRO called Neox s.r.o., with over 150 […]

Emmes Expands Presence in Europe with Neox Acquisition Crosses 1K Employee Mark and Grows in CRO Stature
2 months ago
Share

Velocity Clinical Research Strategic Move to Diversify Patient Enrollment Options: Southern California eStudySite Acquisition

Private equity-backed site organization roll-up Velocity Clinical Research purchased eStudySite, contributing two trial site locations in San Diego, California to […]

Velocity Clinical Research Strategic Move to Diversity Patient Enrollment Options Southern California eStudySite Acquisition
4 months ago
Share

Bayer Acquires Gene Therapy Leader AskBio for up to $4 Billion Deal: Becoming a Global Gene Therapy Powerhouse

Germany-based Bayer acquired AskBio’s industry leading AAV-based gene therapy platform to accelerate its ability to bring urgently needed treatments to […]

Bayer Acquires Gene Therapy Leader AskBio for up to $4 Billion Deal Becoming a Global Gene Therapy Powerhouse
4 months ago
Share

Velocity Clinical Research Acquires Omega Medical Research, Expanding Its Reach to All Four Continental U.S. Time Zones

Paul Evans and Velocity are on the move again buying another research site in their quest to build a seamlessly […]

Velocity Clinical Research Acquires Expanding Its Reach to All Four Continental U.S. Time Zones
9 months ago
Share

Flurry of Merck Deals to Enter COVID-19 Vaccine & Therapy Race—will Tap into Federal Dollars

Merck (NYSE:MRK), known as MSD outside the United States and Canada, has moved into the race to develop COVID-19 treatments, […]

Flurry of Merck Deals to Enter COVID-19 Vaccine & Therapy Race—will Tap into Federal Dollars
9 months ago
Share

How Gilead’s Newest Takeover Deal Will Bolster Its Cancer Strategy

Gilead Sciences (GILD) will buy cancer-focused player Forty Seven (FTSV) for $4.9 billion, the biotech company said Monday, sending FTSV stock rocketing. The deal […]

How Gilead's Newest Takeover Deal Will Bolster Its Cancer Strategy
1 year ago
Share

Astellas to Plug-in-and-Play to Vibrant South San Francisco Immuno-Oncology R&D Ecosystem with Xyphos Buy

Astellas Pharma Inc. acquired Xyphos Biosciences, Inc. to strengthen its immuno-oncology pipeline. With the acquisition Astellas gains Xyphos’ novel and proprietary […]

Astellas to Plug-in-and-Play to Vibrant South San Francisco Immuno-Oncology R&D Ecosystem with Xyphos Buy
1 year ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.